• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Koo
  • Youtube
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

Tag: Covid19 Vaccine

India Willing To Offer Vax Manufacturing Industry To Other Countries: Health Minister
India Willing To Offer Vax Manufacturing Industry To Other Countries: Health Minister

The minister also added that apart from pandemic and health emergencies, there is an ample scope of collaboration among countries like in the field of vaccine preventable diseases with high morbidity and mortality and for those diseases with no vaccines available currently such as AIDS, TB, etc.

Govt Panel Recommends EUA For BE's Covid Jab Corbevax For 12-18 Yrs Age Group
Govt Panel Recommends EUA For BE's Covid Jab Corbevax For 12-18 Yrs Age Group

In an application sent to the DCGI on February 9, Srinivas Kosaraju, the head of Quality and Regulatory Affairs of Biological E Limited said the firm had received approval for conducting phase 2/3 clinical study of Corbevax among children and adolescents aged 5-18 years in September.

US Supreme Court Blocks Federal Vaccine Mandate For Large Businesses
US Supreme Court Blocks Federal Vaccine Mandate For Large Businesses

The court's three liberal justices dissented from the ruling. "When we are wise, we know not to displace the judgments of experts, acting within the sphere Congress marked out and under Presidential control, to deal with emergency conditions," they wrote in the dissenting opinion.

AstraZeneca Vaccine As Third Dose Effective Against Omicron: Study
AstraZeneca Vaccine As Third Dose Effective Against Omicron: Study

AstraZeneca said this data adds to the growing body of evidence supporting Vaxzevria as a third dose booster, irrespective of the primary vaccination schedules tested.

BOOSTER WORKING
COVAXIN Booster Dose Data Shows Promising Results

COVAXIN Booster Dose Data Shows Promising Results

Video Icon
CoWIN
Online Appointment Feature For Precaution Dose Starts On CoWIN

The feature of online appointment for precautionary dose was made operational on the CoWIN portal on Saturday late night. Those eligible to receive precaution dose of Covid vaccines can book online appointment.

US FDA Authorizes Pfizer-BioNTech Boosters For Kids Aged 12-15
US FDA Authorizes Pfizer-BioNTech Boosters For Kids Aged 12-15

The decision came as the Omicron variant is spreading rapidly across the US and has led to record high hospitalisations among younger people.

Over 40 Lakh Children Get COVID-19 Vaccine On First Day
Over 40 Lakh Children Get COVID-19 Vaccine On First Day

With the drive starting mostly from schools, many principals and other officials said they received a positive response from students and their families.

Omicron: Existing COVID19 Vaccine Not Effective, Boosters May Help, Say Experts
Omicron: Existing COVID19 Vaccine Not Effective, Boosters May Help, Say Experts

The Indian Council of Medical Research also said recently that all Covid vaccines do not prevent infection and are primarily disease-modifying.

WHO
WHO Warning On COVID19 Vaccine Booster Programs

WHO Director General issues Strategic Advisory Group of Experts on Immunization’s (SAGE) interim statement on booster doses.

Video Icon
Mansukh Mandaviya
India's 60% Eligible Population Fully Vaccinated: Mandaviya

India on Thursday registered 7,495 fresh Covid cases and 434 deaths in a span of 24 hours.

COVID Vaccine
Mandaviya Says First COVID Vaccine Dose Given To 86 Pc Of Eligible Population

To a query related to Omicron, he said that studies are going on and only after the studies are complete, it will be known which vaccine is how much effective against the new variant.

Pfizer Vax 40 Times Less Effective Against Omicron: South African Study
Pfizer Vax 40 Times Less Effective Against Omicron: South African Study

Meanwhile top US infectious disease expert Anthony Fauci said that early data on the Omicron Covid-19 variant is a "bit encouraging" and does not indicate a great degree of danger, says.

Mixing Other Vaccines With AstraZeneca, Pfizer Jabs Generates Robust Immune Response: Lancet Study
Mixing Other Vaccines With AstraZeneca, Pfizer Jabs Generates Robust Immune Response: Lancet Study

In addition, a significantly higher number of short-lived vaccine reactions were reported in volunteers who received a second dose of Moderna compared to those who received two doses of either AstraZeneca or Pfizer.

Covishield Found 63% Effective In Fully Vaccinated Individuals During 2nd Surge
Covishield Found 63% Effective In Fully Vaccinated Individuals During 2nd Surge

The study provides comprehensive data on the real-world vaccine effectiveness and immunological response to vaccination which should help guide policy. The study thus implies that the vaccines continued to be effective in protecting against severe disease and death regardless of the variants.

Supreme Court
Can't Cast Doubt On Vaccination: SC On Plea Seeking probe on deaths linked to vaccine

Justice Chandrachud emphasized, "When you have guidelines, why should the court interfere at this crucial stage of vaccination? Every country in the world has multiple vaccines...look at the developed world, the US."

COVID19 vaccine
15 More Nations Recognise India's Covid Vaccines

The Union ministry of health and family welfare said earlier that nearly 100 countries have agreed to the mutual acceptance of vaccination certificates of India's Covid-19 vaccines and the vaccination process.

Covaxin
Covaxin Shows 50% Effectiveness Against Symptomatic COVID-19 In Real-World Assessment: Lancet Study

The research was conducted during the peak of India's second wave of COVID-19 with high test positivity rates for both hospital employees and residents of Delhi, they said.

Vaccination Rate In Odisha Slower
Only 47% Fully Vaccinated In Odisha Vs 52% In Assam, State Lags Behind Chhattisgarh

An analysis reveals that Odisha has very fewer vaccination sites to inoculate its eligible population. Chhattisgarh and Assam have opened 4,300 and 3,489 vaccination sites, respectively, against a mere 2,194 in Odisha

Booster Dose: What Top Health Experts Have To Say
Booster Dose: What Top Health Experts Have To Say

Citing the reasons for booster dose in the US, he said that the Delta variant is causing infections in European countries and that is also a reason for booster dose there. However, India has passed that phase now. "Healthcare workers were the first to be vaccinated. But no case has yet come after around 9 to 10 months which can advocate the need for the booster doses in India", opined Dr Seth.

Novavax
Centre Allows Export Of 20Million Novavax Doses To Indonesia

Meanwhile, a total of 110 countries have recognised India's vaccines, Covishield and Covaxin, and agreed to the mutual recognition of Covid-19 vaccination certificates with India.

India Now Being Called 'Pharmacy Of The World': PM Modi
India Now Being Called 'Pharmacy Of The World': PM Modi

He inaugurated the first Global Innovation Summit of the pharmaceuticals sector on Thursday. Union Minister Dr. Mansukh Mandaviya was also present on the occasion.

India Exported Over 65 Million Doses Of Covid Vaccines To Nearly 100 Countries This Year: PM Modi
India Exported Over 65 Million Doses Of Covid Vaccines To Nearly 100 Countries This Year: PM Modi

Noting that India has a large pool of scientists and technologists with a potential to take the industry to greater heights, Modi said this strength needs to be harnessed to discover and make in India .

Number Of People Fully Vaccinated Against COVID-19 Surpasses Those Partially Vaccinated
Number Of People Fully Vaccinated Against COVID-19 Surpasses Those Partially Vaccinated

The Union Health Minister expressed confidence that the country will have vaccinated every Indian by the end of the month-long 'Har Ghar Dastak' campaign, according to the statement.

 Covaxin
Covaxin 77.8% Effective Against COVID-19: Lancet study

The phase 3 trial Efficacy and Safety Study involving 25,800 volunteers across 25 sites in India is India's largest ever clinical trial conducted for a Covid-19 vaccine.

Indian Origin Scientist Named Primary Contributor To Invention Of Moderna's Covid Vaccine
Indian Origin Scientist Named Primary Contributor To Invention Of Moderna's Covid Vaccine

Moderna's is of the new class of vaccines that use what is called messenger RNA (mRNA) that cause the body to create some proteins similar to that in the Covid-19 virus and trigger the body's immune system to make antibodies that will fight the coronavirus if it invades the body.

Bharat Biotech's US Partner Ocugen Seeks Covaxin Approval For Kids
Bharat Biotech's US Partner Ocugen Seeks Covaxin Approval For Kids

Covaxin uses the same Vero Cell manufacturing platform as other childhood vaccines, including the inactivated polio vaccine.

US CDC Advisors Recommend Pfizer's Covid-19 Vaccine For Children Aged 5-11
US CDC Advisors Recommend Pfizer's Covid-19 Vaccine For Children Aged 5-11

"The vaccine is one-third the adult dose and the vaccine would be given in two doses, three weeks apart. "

Third Pfizer Vaccine Dose More Effective In Reducing Severe COVID Illness: Lancet
Third Pfizer Vaccine Dose More Effective In Reducing Severe COVID Illness: Lancet

For the study, published in The Lancet journal, the team reviewed data from 7,28,321 individuals aged 12 or above who had received the third dose of the BNT162b2 vaccine.

WHO Body Seeks More Clarification To Decide On Covaxin EUL
WHO Body Seeks More Clarification To Decide On Covaxin EUL

Hyderabad based Bharat Biotech is expected to submit the data by this weekend.

COVID-19 Vaccine
Don't Cast Doubt On Vaccination: SC Junks Plea Against Mass Vax Of Covishield, Covaxin

The top court told the petitioner's counsel that it finds no error with the high court decision in the matter, and it will not entertain the petition.

Pfizer Says Its Covid Vax 90.7% Effective In Kids Aged 5-11
Pfizer Says Its Covid Vax 90.7% Effective In Kids Aged 5-11

If authorised, Pfizer-BioNTech vaccine would be the first Covid-19 vaccine for younger children.

Pfizer To Soon Submit Data On COVID Vaccine For Kids Aged 5-11
Pfizer To Soon Submit Data On COVID Vaccine For Kids Aged 5-11

Last week, the US drugmaker and its German partner BioNTech, in a study, showed that their mRNA Covid vaccine is safe, well tolerated and produces robust neutralising antibody responses in children aged 5 to 11 years.

PM Modi At UNGA Invites Vaccine Manufacturers Across The World To 'Make In India'
PM Modi At UNGA Invites Vaccine Manufacturers Across The World To 'Make In India'

On Monday, India said it will resume export of surplus COVID-19 vaccines in the fourth quarter of 2021 under the ''Vaccine Maitri'' programme and to meet its commitment to the COVAX global pool.

Centre Plans To Procure 20 Cr Covishield, 1 Cr Zydus RNA Vaccine Doses In September
Centre Plans To Procure 20 Cr Covishield, 1 Cr Zydus RNA Vaccine Doses In September

Stating that there is no shortage of vaccines in the country, the source said that the Centre is capable of supplying as many vaccine doses the states need, in real-time without any delay.

ICMR Gets Civil Aviation Ministry Nod To Use Drones For Vaccine Delivery
ICMR Gets Civil Aviation Ministry Nod To Use Drones For Vaccine Delivery

Earlier, Union Minister for Civil Aviation Jyotiraditya Scindia had launched the first of its kind ‘Medicines from the Sky' project at Vikarabad in Telangana under which drugs and vaccines were to be delivered using drones on September 11.

Over 74 Cr COVID Vaccine Jabs Administered In India
Over 74 Cr COVID Vaccine Jabs Administered In India

The countrywide vaccination drive was rolled out on January 16 with healthcare workers getting inoculated in the first phase. Vaccination of frontline workers started on February 2.

Moderna To Develop Single-Dose Booster Shot For COVID19
Moderna To Develop Single-Dose Booster Shot For COVID19

Moderna is developing vaccines against viral diseases including vaccines against acute respiratory infections, vaccines against persistent infections, as well as vaccines against threats to global public health.

Brazil Bans China's Sinovac Covid Vaccine Over Fears Of Contamination
Brazil Bans China's Sinovac Covid Vaccine Over Fears Of Contamination

They aim to avoid the use of irregular or suspect products," Anvisa said. The lack of information about the environment at the production bases, combined with the need for vaccine shots to be made in strictly aseptic settings, persuaded officials to take the measure, Anvisa said.

Focus On 60+, Administer 2nd Dose To Eligible Persons: Centre
Focus On 60+, Administer 2nd Dose To Eligible Persons: Centre

Bhushan also discussed the details of the states and UT's balance stock of 0.5 ml syringes, vaccination coverage among special groups (Transgender Persons, Persons with Disabilities, PWI and Prisoners), Covid vaccination coverage among women particularly pregnant and lactating.

scrollToTop